Document is current
Any future updates will be listed below
-
Authors
Della Corte, Carminia Maria
Ciaramella, Vincenza
Ramkumar, Kavya
Vicidomini, Giovanni
Fiorelli, Alfonso
Nardone, Valerio
Cappabianca, Salvatore
Cozzolino, Immacolata
Zito Marino, Federica
Di Guida, Gaetano
Wang, Qi
Cardnell, Robert
Gay, Carl Michael
Ciardiello, Davide
Martinelli, Erika
Troiani, Teresa
Martini, Giulia
Napolitano, Stefania
Wang, Jing
Byers, Lauren Averett
Ciardiello, Fortunato
Morgillo, Floriana http://orcid.org/0000-0002-9167-323X
-
Funding
Funding for this research was provided by:
Incyte
Associazione Italiana per la Ricerca sul Cancro (MFAG 26237)
- License Information
-
More Information
Article History
Received: 30 September 2022
Accepted: 25 October 2022
First Online: 22 November 2022
Declarations
:
: Ethics approval and consent to participate: Patients involved in the study have been enrolled in the V:org study, approved by Ethical Committee (n.280 del 16 May 2020) and have signed the specific informed consent for participation.
: Not applicable.
: CMDC, advisory board MSD, Roche, Astra Zeneca, travel grants Amgen; CMG, Advisory Board—Jazz Pharmaceuticals, AstraZeneca, Bristol Myers Squibb, Monte Rosa Therapeutics; Speaker’s Bureau—AstraZeneca, BeiGene; EM, advisor and speaker for Astra Zeneca, Amgen, Bayer, Merck-Serono, Roche, Sanofi, Servier, Pierre Fabre; TT, advisor and speaker for Roche, Merck-Serono, Sanofi, Servier, Novartis, Bayer; L.A.B., advisory committees for Merck Sharp & Dohme Corp., Arrowhead Pharmaceuticals, Chugai Pharmaceutical Co., AstraZeneca, Genetech Inc., Abbvie, BeiGene, Jazz Pharmaceuticals, research funding from AstraZeneca, Amgen, Jazz Pharmaceuticals; FM: advisory boards: MSD, Lilly; institutional research grants: AstraZeneca; FC, advisor and speaker for Roche, Amgen, Merck-Serono, Pfizer, Sanofi, Bayer, Servier, BMS, Cellgene, Lilly, institutional Research Grants form Bayer, Roche, Merck-Serono, Amgen, AstraZeneca, Takeda. Other authors have no conflicts of interest to declare.
